Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Karyopharm Therapeutics Has a Unique Growth Opportunity

TheMotleyFool

0 0

Here's Why Karyopharm Therapeutics Has a Unique Growth Opportunity

Cancer-drug maker Karyopharm Therapeutics (NASDAQ: KPTI) has seen phenomenal growth since early 2019, with its stock up more than 60% in a bit more than a year.

The 12-year-old company is pioneering novel drugs that will help treat patients with certain blood cancers or solid tumors. Over the past six months alone, the stock has generated gains of 72%. So what's generating all this buzz?

IMAGE SOURCE: GETTY IMAGES.

Source Fool.com

Like: 0

KPTI

Share